Ergebnis der Suchanfrage nach @r@Borna@dokument

Inhalte

Filtern
641 Treffer
  • 17.08.2020 – 11:26

    Technische Universität München

    Designed bacteria produce coral-antibiotic

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36204/ High resolution images: https://mediatum.ub.tum.de/1554685 NEWS RELEASE Sustainable biotechnological production of a natural substance against tuberculosis Designed bacteria produce coral-antibiotic Corals growing on the reefs of ...

  • 29.07.2020 – 13:50

    Technische Universität München

    How stony-iron meteorites form - SAPHiR multi-anvil press solves mystery of the solar system

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36181/ High resolution images: https://mediatum.ub.tum.de/1554164 NEWS RELEASE How stony-iron meteorites form SAPHiR multi-anvil press solves mystery of the ...

  • 28.07.2020 – 11:25

    Technische Universität München

    TUM strengthens Campus Heilbronn with informatics

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36178/ NEWS RELEASE TUM strengthens Campus Heilbronn with informatics Dieter Schwarz Stiftung to fund 11 more professorships The Heilbronn campus of the Technical University of Munich (TUM) is taking on a ...

  • 23.06.2020 – 15:58

    IgNova GmbH

    IgNova files patent application on antibody against COVID-19

    Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...